private:epistemholdings
|
245764
|
May 24th, 2019 12:00AM
|
Epistem Ltd.
|
2.0K
|
52.00
|
Open
|
Biotechnology
|
May 24th, 2019 03:19PM
|
May 24th, 2019 03:19PM
|
Epistem Ltd. is a leading contract service provider offering innovative preclinical research services, genetic and protein biomarker testing as well as histology services to pharmaceutical, biotech and academic customers to support to drug discovery and development pipelines.
We have worked with over 200 pharmaceutical and biotechnology companies at both preclinical and clinical stages. Our high level of expertise and customer focus has led to an enviable track record and impressive amount of repeat business.
Our preclinical contract research services group advance drug development programs for oncology, inflammatory, dermatology, auto-immune and GI disease indications. We offer an impressive range of preclinical models in these therapeutic areas. We also provide information relating to toxicity assessments and are experts in GI tox. We also offer a broad range of cell based assays including novel stem cell assays.
Our biomarker services division offers GCLP compliant genetic testing, histology, FACS analysis and protein biomarker detection.
Epistem’s genetics group offer gene expression and DNA genotyping sample analysis by NGS, microarray and qPCR. We specialise in working with small starting materials (down to a single cell input) applying our proprietary low input techniques and products to support drug development programs. We are specialists in fractionating cell populations and conducting genetic analysis. We have pioneered techniques using plucked scalp hair and laser capture microdissected material to provide gene expression biomarker information to drug development programs.
Epistem is committed to provide reliable and innovative services to support all phases of drug development from to preclinical projects to clinical trials.
Website: www.epsitem.co.uk
|
Open
|
GCLP, drug development, therapeutics, oncology, contract research, gene expression, biomarkers, dermatology, mucositis, preclinical, inflammatory bowel disease, IBD, angiogenesis, histology, wound healing, radiation, molecular diagnostics, hair research/growth
|
Open
|
48 Grafton Street
|
Manchester
|
Lancashire
|
GB
|
M13 9XX
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 17th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 16th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 15th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 14th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 13th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 12th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 11th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 10th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|
private:epistemholdings
|
245764
|
Feb 9th, 2018 12:00AM
|
Epistem Ltd.
|
1.7K
|
67.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Epistem is a biotechnology company with a specialist understanding of epithelial tissue and adult stem cell analyses.
The Contract Research Division delivers innovative preclinical research services in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Working with over 150 pharmaceutical, biotechnology, and personal care companies worldwide, it offers proprietary assays for target validation, screening, efficacy, and translational biology.
The Pharmacogenomics Division is committed to facilitating a more tailored approach to patient treatment and care by providing RNA and DNA analysis. It applies innovative gene expression to discover novel drug-induced biomarkers to GCLP accredited quality standards.
The Company has pioneered a technique using single plucked scalp hair, as a surrogate biomarker tissue, to monitor responses to drug treatment. Information using hair can be obtained either from preclinical models, human scalp hair treated ex vivo or from clinical trial samples.
|
|
|
|
|
|
|
|
|
|
Epistem Holdings
|
|
|